163 related articles for article (PubMed ID: 37483852)
21. The Cancer of the Bladder Risk Assessment (COBRA) score accurately predicts cancer-specific survival after radical cystectomy: external validation and lymphovascular invasion assessment value to improve its performance.
Colomer Gallardo A; Candela L; Buisan Rueda O; Freixa Sala R; Elias Cañavera J; Moschini M; Macek P; Bennamoun M; Mombet A; Cathelineau X; Areal Calama JJ; Sánchez-Salas R
Clin Genitourin Cancer; 2022 Jun; 20(3):199-209. PubMed ID: 35042666
[TBL] [Abstract][Full Text] [Related]
22. A systematic review and meta-analysis of lymphovascular invasion in patients treated with radical cystectomy for bladder cancer.
Mari A; Kimura S; Foerster B; Abufaraj M; D'Andrea D; Gust KM; Shariat SF
Urol Oncol; 2018 Jun; 36(6):293-305. PubMed ID: 29685374
[TBL] [Abstract][Full Text] [Related]
23. Association of Pre- and Posttreatment Neutrophil-Lymphocyte Ratio With Recurrence and Mortality in Locally Advanced Non-Small Cell Lung Cancer.
Sebastian NT; Raj R; Prasad R; Barney C; Brownstein J; Grecula J; Haglund K; Xu-Welliver M; Williams TM; Bazan JG
Front Oncol; 2020; 10():598873. PubMed ID: 33251151
[TBL] [Abstract][Full Text] [Related]
24. The prognostic value of the neutrophil-to-lymphocyte ratio in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomy.
Black AJ; Zargar H; Zargar-Shoshtari K; Fairey AS; Mertens LS; Dinney CP; Mir MC; Krabbe LM; Cookson MS; Jacobsen NE; Griffin J; Montgomery JS; Vasdev N; Yu EY; Xylinas E; Campain NJ; Kassouf W; Dall'Era MA; Seah JA; Ercole CE; Horenblas S; McGrath JS; Aning J; Shariat SF; Wright JL; Thorpe AC; Morgan TM; Holzbeierlein JM; Bivalacqua TJ; North S; Barocas DA; Lotan Y; Grivas P; Stephenson AJ; Shah JB; van Rhijn BW; Spiess PE; Daneshmand S; Sridhar SS; Black PC
Urol Oncol; 2020 Jan; 38(1):3.e17-3.e27. PubMed ID: 31676278
[TBL] [Abstract][Full Text] [Related]
25. Urothelial carcinoma of the bladder with isolated lymph node metastasis: Natural history and outcomes following surgical resection.
Morton E; Kaul S; Fleishman A; Korets R; Chang P; Wagner A; Kim SP; Bellmunt J; Kaplan I; Olumi AF; Gershman B
Urol Oncol; 2023 May; 41(5):255.e7-255.e14. PubMed ID: 36470805
[TBL] [Abstract][Full Text] [Related]
26. Oncological outcomes of concomitant carcinoma in situ at radical cystectomy in pure urothelial bladder cancer and in histological variants.
Naspro R; La Croce G; Finati M; Roscigno M; Pellucchi F; Sodano M; Manica M; Gianatti A; Da Pozzo LF
Urol Oncol; 2022 Feb; 40(2):61.e9-61.e19. PubMed ID: 34334293
[TBL] [Abstract][Full Text] [Related]
27. Neutrophil-to-lymphocyte ratio predicts progression and recurrence of non-muscle-invasive bladder cancer.
Mano R; Baniel J; Shoshany O; Margel D; Bar-On T; Nativ O; Rubinstein J; Halachmi S
Urol Oncol; 2015 Feb; 33(2):67.e1-7. PubMed ID: 25060672
[TBL] [Abstract][Full Text] [Related]
28. The Value of Preoperative Plasma VEGF Levels in Urothelial Carcinoma of the Bladder Treated with Radical Cystectomy.
Mori K; Schuettfort VM; Katayama S; Laukhtina E; Pradere B; Quhal F; Sari Motlagh R; Mostafaei H; Grossmann NC; Rajwa P; König F; Aydh A; Soria F; Moschini M; Karakiewicz PI; Lotan Y; Scherr D; Haydter M; Nyirady P; Teoh JYC; Egawa S; Compérat E; Shariat SF
Eur Urol Focus; 2022 Jul; 8(4):972-979. PubMed ID: 34454852
[TBL] [Abstract][Full Text] [Related]
29. Prognostic Model for Predicting Survival in Patients with Disease Recurrence Following Radical Cystectomy.
Kluth LA; Xylinas E; Rieken M; Kent M; Ikeda M; Matsumoto K; Hagiwara M; Kikuchi E; Bing MT; Gupta A; Sewell JM; Konety BR; Todenhöfer T; Schwentner C; Masson-Lecomte A; Vordos D; Roghmann F; Noldus J; Razmaria AA; Smith ND; Comploj E; Pycha A; Rink M; Baniel J; Mano R; Novara G; Aziz A; Fritsche HM; Brisuda A; Bivalacqua T; Gontero P; Boorjian SA; Vickers AJ; Shariat SF
Eur Urol Focus; 2015 Aug; 1(1):75-81. PubMed ID: 28723361
[TBL] [Abstract][Full Text] [Related]
30. Impact of the preoperative modified Glasgow Prognostic Score on disease outcome after radical cystectomy for urothelial carcinoma of the bladder.
Schuettfort VM; Gust K; D'Andrea D; Quhal F; Mostafaei H; Laukhtina E; Mori K; Rink M; Abufaraj M; Karakiewicz PI; Luzzago S; Rouprêt M; Enikeev D; Zimmermann K; Deuker M; Moschini M; Sari Motlagh R; Grossmann NC; Katayama S; Pradere B; Shariat SF
Minerva Urol Nephrol; 2022 Jun; 74(3):302-312. PubMed ID: 34114784
[TBL] [Abstract][Full Text] [Related]
31. Long Non-Coding RNA Cancer Susceptibility Candidate 2a (CASC2a) Is a Marker of Early Recurrence After Radical Cystectomy in Patients with Urothelial Carcinoma of the Bladder.
Li Z; Wang KE; Zhou XL; Zhou J; Ye CH
Med Sci Monit; 2018 Jan; 24():438-447. PubMed ID: 29358570
[TBL] [Abstract][Full Text] [Related]
32. Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis.
Fajkovic H; Cha EK; Jeldres C; Robinson BD; Rink M; Xylinas E; Chromecki TF; Breinl E; Svatek RS; Donner G; Tagawa ST; Tilki D; Bastian PJ; Karakiewicz PI; Volkmer BG; Novara G; Joual A; Faison T; Sonpavde G; Daneshmand S; Lotan Y; Scherr DS; Shariat SF
Eur Urol; 2013 Nov; 64(5):837-45. PubMed ID: 22877503
[TBL] [Abstract][Full Text] [Related]
33. Neutrophil-to-lymphocyte ratio as a predictor of overall survival and cancer advancement in patients undergoing radical cystectomy for bladder cancer.
Sudoł D; Widz D; Mitura P; Płaza P; Godzisz M; Kuliniec I; Yadlos A; Cabanek M; Bar M; Bar K
Cent European J Urol; 2022; 75(1):41-46. PubMed ID: 35591971
[TBL] [Abstract][Full Text] [Related]
34. Prediction of outcome in patients with urothelial carcinoma of the bladder following radical cystectomy using artificial neural networks.
Buchner A; May M; Burger M; Bolenz C; Herrmann E; Fritsche HM; Ellinger J; Höfner T; Nuhn P; Gratzke C; Brookman-May S; Melchior S; Peter J; Moritz R; Tilki D; Gilfrich C; Roigas J; Zacharias M; Hohenfellner M; Haferkamp A; Trojan L; Wieland WF; Müller SC; Stief CG; Bastian PJ
Eur J Surg Oncol; 2013 Apr; 39(4):372-9. PubMed ID: 23465180
[TBL] [Abstract][Full Text] [Related]
35. Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor.
Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
Oncotarget; 2017 Feb; 8(8):12891-12901. PubMed ID: 28039452
[TBL] [Abstract][Full Text] [Related]
36. Lymphovascular invasion is an independent predictor of oncological outcomes in patients with lymph node-negative urothelial bladder cancer treated by radical cystectomy: a multicentre validation trial.
Bolenz C; Herrmann E; Bastian PJ; Michel MS; Wülfing C; Tiemann A; Buchner A; Stief CG; Fritsche HM; Burger M; Wieland WF; Höfner T; Haferkamp A; Hohenfellner M; Müller SC; Ströbel P; Trojan L
BJU Int; 2010 Aug; 106(4):493-9. PubMed ID: 20067452
[TBL] [Abstract][Full Text] [Related]
37. The impact of variant histological differentiation on extranodal extension and survival in node positive bladder cancer treated with radical cystectomy.
Marks P; Gild P; Soave A; Janisch F; Minner S; Engel O; Vetterlein MW; Shariat SF; Sauter G; Dahlem R; Fisch M; Rink M
Surg Oncol; 2019 Mar; 28():208-213. PubMed ID: 30851902
[TBL] [Abstract][Full Text] [Related]
38. Gender-specific differences in clinicopathologic outcomes following radical cystectomy: an international multi-institutional study of more than 8000 patients.
Kluth LA; Rieken M; Xylinas E; Kent M; Rink M; Rouprêt M; Sharifi N; Jamzadeh A; Kassouf W; Kaushik D; Boorjian SA; Roghmann F; Noldus J; Masson-Lecomte A; Vordos D; Ikeda M; Matsumoto K; Hagiwara M; Kikuchi E; Fradet Y; Izawa J; Rendon R; Fairey A; Lotan Y; Bachmann A; Zerbib M; Fisch M; Scherr DS; Vickers A; Shariat SF
Eur Urol; 2014 Nov; 66(5):913-9. PubMed ID: 24331151
[TBL] [Abstract][Full Text] [Related]
39. Radical cystectomy for pT1 urothelial carcinoma of bladder not amenable to TURBT: Long-term results.
Ma B; Li Y; Han S; Jiang X; Zhao Y; Guo J; Quan C; Niu Y
Eur J Surg Oncol; 2019 Oct; 45(10):1993-1999. PubMed ID: 31327502
[TBL] [Abstract][Full Text] [Related]
40. Predictive value of lymphangiogenesis and proliferation markers on mRNA level in urothelial carcinoma of the bladder after radical cystectomy.
Martini T; Heinkele J; Mayr R; Weis CA; Wezel F; Wahby S; Eckstein M; Schnöller T; Breyer J; Wirtz R; Ritter M; Bolenz C; Erben P
Urol Oncol; 2018 Dec; 36(12):530.e19-530.e27. PubMed ID: 30446441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
